- Trials with a EudraCT protocol (39)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
39 result(s) found for: Neural Activity.
Displaying page 1 of 2.
EudraCT Number: 2006-005139-61 | Sponsor Protocol Number: EB064 | Start Date*: 2006-10-24 |
Sponsor Name:Emotional Brain | ||
Full Title: Neural correlates of sexual arousal during treatment of testosterone combined with sildenafil in healthy female subjects with FSD. Effects of differing levels of attentional engagement on neural co... | ||
Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001496-21 | Sponsor Protocol Number: LOC-2013 | Start Date*: 2013-06-18 |
Sponsor Name:Harry Scheinin | ||
Full Title: The Neural Mechanisms of Anesthesia and Human Consciousness | ||
Medical condition: No medical condition or disease involved. The study subjects are healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000257-56 | Sponsor Protocol Number: EB065 | Start Date*: 2007-02-05 |
Sponsor Name:Emotional Brain BV | ||
Full Title: Neural correlates of sexual arousal during treatment of testosterone combined with sildenafil in healthy female subjects with FSD. Effects of differing levels of attentional engagement on neural co... | ||
Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002701-23 | Sponsor Protocol Number: SK200504, 28.04.2005 | Start Date*: 2005-08-14 |
Sponsor Name:Siegfried Kasper, O.Univ.Prof.Dr.Dr.h.c. | ||
Full Title: Escitalopram versus Citalopram Treatment effects on cortical and subcortical activity assessed by pharmacological fMRI | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004487-25 | Sponsor Protocol Number: KETASELF-1 | Start Date*: 2021-02-08 |
Sponsor Name:Linköpings Universitet | ||
Full Title: Experiencing the self through touch - self-other-distinction in an altered state of self: An exploratory randomized placebo-controlled experimental medicine study | ||
Medical condition: Healthy volunteer. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000206-36 | Sponsor Protocol Number: DOPA1 | Start Date*: 2014-10-27 |
Sponsor Name: | ||
Full Title: DRD4 genotype as a moderator of L-Dopa intervention effects on parent-related neurocognitive processes, behaviors, and attitudes: A micro-trial of differential susceptibility to pharmacological int... | ||
Medical condition: There are no medical conditions or diseases under investigation. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001573-28 | Sponsor Protocol Number: Uni-Koeln-320 | Start Date*: 2007-11-26 |
Sponsor Name:Universität zu Köln | ||
Full Title: Prevent: Secondary Prevention of Schizophrenia. A randomized controlled trial. | ||
Medical condition: Persons at risk of being prodromally symptomatic of psychosis (PAR) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005773-27 | Sponsor Protocol Number: APHP190353 | Start Date*: 2021-03-09 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: BARIcitinib Cognitive Emotional and Neural signaTuRE BARICENTRE | |||||||||||||
Medical condition: Patients with rheumatoid arthritis and indication of baricitinib treatment according to a rheumatologist | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003728-39 | Sponsor Protocol Number: OTMother2014 | Start Date*: 2014-12-16 |
Sponsor Name:Tampere University Hospital | ||
Full Title: Effects of maternal oxytocin on social information processing in mothers | ||
Medical condition: There are no medical conditions or diseases under investigation, participants are healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022511-18 | Sponsor Protocol Number: X04 | Start Date*: 2011-04-05 | |||||||||||
Sponsor Name:Albert-Ludwig University Freiburg, Laboratory for Biological and Personality Psychology | |||||||||||||
Full Title: Behavioral effects and neural correlates of oxytocin on social attention [Verhaltenseffekte und neuronales Korrelat von Oxytocin im Kontext sozialer Aufmerksamkeit] | |||||||||||||
Medical condition: subjects with autism spectrum disorder and neurotypical controls | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003061-25 | Sponsor Protocol Number: MPEEG_2 | Start Date*: 2016-12-14 |
Sponsor Name:Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg | ||
Full Title: Pharmaco-EEG for Montelukast. Can we detect neural changes during medication with Montelukast in the EEG? | ||
Medical condition: Montelukast is indicated for prophylaxis and chronic treatment of asthma and for the relief of symptoms of seasonal allergic rhinitis. We investigate side effects of Montelukast, specifically poten... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000454-22 | Sponsor Protocol Number: NL43068.058.13 | Start Date*: 2013-08-21 | |||||||||||
Sponsor Name: | |||||||||||||
Full Title: (Grand)parenting, oxytocin, and the oxytocin receptor gene: an fMRI and observational study | |||||||||||||
Medical condition: There are no medical conditions or diseases under investigation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004857-27 | Sponsor Protocol Number: F20REWARDLU | Start Date*: 2008-01-02 |
Sponsor Name:Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich | ||
Full Title: Ventral striatal function in patients with schizophrenia before and under medication with atypical antipsychotics: a comparison of sertindole and risperidone | ||
Medical condition: schizophrenic patients (F20.0, F20.1, F20.2, F20.3, F20.5, F20.6, F20.8, F20.9) and healthy controls | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-017163-42 | Sponsor Protocol Number: MR2010 | Start Date*: 2010-05-18 |
Sponsor Name:Karolinska Institute | ||
Full Title: Pain modulation in RA – Influence of adalimumab. A randomized, placebo-controlled study using functional magnetic resonance imaging | ||
Medical condition: Rheumatoid arthritis (RA) The overall aim with this project is to investigate central pain mechanisms in RA and healthy controls, and in RA how these are influenced by autonomic neural regulatio... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001719-19 | Sponsor Protocol Number: 2016:1 | Start Date*: 2016-07-25 |
Sponsor Name:Uppsala University | ||
Full Title: Selecitve progesterone receptor modulators for treatment of premenstrual dysphoric disorder. A randomized, double-blind, placebo controlled study. | ||
Medical condition: Premenstrual dysphoric disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012449-48 | Sponsor Protocol Number: ALS-8-09-A-101 | Start Date*: 2009-11-09 |
Sponsor Name:Air Liquide Santé International | ||
Full Title: „Sympathetic neural outflow during Xenon anesthesia in humans“ | ||
Medical condition: We would like to frame the thesis, that a general, inhalative Xenon anesthesia (1 MAC) does not effect the sympathetic outflow and the sympathetic baroreflex reagibility under spontaneous breathing... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001217-25 | Sponsor Protocol Number: 2016-001217-25 | Start Date*: 2016-09-07 |
Sponsor Name:Uppsala University | ||
Full Title: Emotion, Serotonin and Premenstrual Dysphoric Disorder (EmSeP) | ||
Medical condition: Premenstrual Dysphoric Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000769-35 | Sponsor Protocol Number: S61358 | Start Date*: 2018-09-27 | |||||||||||
Sponsor Name:University Hospital, KU Leuven | |||||||||||||
Full Title: In search for an innovative neural marker and intervention for socio-communicative difficulties in children with and without autism spectrum disorders | |||||||||||||
Medical condition: Autism Spectrum Disorders | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002959-34 | Sponsor Protocol Number: RETRAP | Start Date*: 2013-03-11 | |||||||||||
Sponsor Name:Sønderjylland Hospital, department of neurology | |||||||||||||
Full Title: RETRAP - A double blind, randomized, placebo controlled study of the effect of the combination of resistance training and prolonged release fampridine on muscle strength in the lower extremities, w... | |||||||||||||
Medical condition: Multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002179-27 | Sponsor Protocol Number: AUT032063 | Start Date*: 2014-08-29 | |||||||||||
Sponsor Name:Autifony Therapeutics Limited | |||||||||||||
Full Title: A Balanced Randomised Placebo Controlled Double-blind Phase IIa Study to Investigate the Efficacy and Safety of AUT00063 Versus Placebo in Subjective Tinnitus | |||||||||||||
Medical condition: Subjects suffering with noise and/or age-related tinnitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.